Smart implant fights swelling to boost hearing
NCT ID NCT06424262
Summary
This study is testing a new type of cochlear implant designed to slowly release a common anti-inflammatory steroid (dexamethasone) after surgery. The goal is to see if reducing swelling around the implant leads to better device performance and hearing results compared to a standard implant. The trial involves 48 adults with severe to profound hearing loss in both ears who are eligible for a cochlear implant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEARING LOSS, SENSORINEURAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Universitaire Toulouse
Toulouse, France
-
Centre Hospitalier Universitaire de Lille
Lille, France
-
Hôpital Universitaire Pitié-Salpêtrière
Paris, France
-
Macquarie University
Sydney, New South Wales, Australia
-
Manchester Royal Infirmary
Manchester, United Kingdom
-
Medizinische Hochschule Hannover
Hanover, Lower Saxony, Germany
-
Royal Prince Alfred Hospital
Sydney, New South Wales, Australia
-
Royal Victorian Eye and Ear Hospital
Melbourne E., Victoria, Australia
-
St Vincent Private Hospital
Melbourne, Victoria, Australia
-
Universitätsklinikum Freiburg
Freiburg im Breisgau, Freiburg Im Breisgau, Germany
-
Westmead Private Hospital
Sydney, New South Wales, Australia
Conditions
Explore the condition pages connected to this study.